id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2020-E-2364-0007,FDA,FDA-2020-E-2364,Notice of Final Determination and Requirement for Election Letter,Other,Letter(s),2024-02-21T05:00:00Z,2024,2,2024-02-21T05:00:00Z,,2024-02-21T21:47:25Z,,0,0,09000064863ee7f0
FDA-2020-E-2364-0006,FDA,FDA-2020-E-2364,Letter to U S Patent and Trademark Office,Other,Letter(s),2023-05-11T04:00:00Z,2023,5,2023-05-11T04:00:00Z,,2023-05-11T13:55:33Z,,0,0,09000064859f44e5
FDA-2020-E-2364-0005,FDA,FDA-2020-E-2364,Determination of Regulatory Review Period for Purposes of Patent Extension; NURTEC ODT,Notice,Determinations,2022-09-23T04:00:00Z,2022,9,2022-09-23T04:00:00Z,2022-11-23T04:59:59Z,2022-09-23T14:04:27Z,2022-20634,0,0,090000648535a9bc
FDA-2020-E-2364-0004,FDA,FDA-2020-E-2364,"Letter from FDA CDER to U.S, Patent and Trademark Office",Other,Letter(s),2022-09-08T04:00:00Z,2022,9,2022-09-08T04:00:00Z,,2022-09-08T19:47:33Z,,0,0,09000064852d12fa
FDA-2020-E-2364-0003,FDA,FDA-2020-E-2364,Letter to U S Patent and Trademark Office,Other,Letter(s),2021-03-01T05:00:00Z,2021,3,2021-03-01T05:00:00Z,,2021-03-01T18:34:00Z,,0,0,0900006484a57ef3
FDA-2020-E-2364-0002,FDA,FDA-2020-E-2364,"Patent Term Extension Application for NURTEC ODT® Patent No 8,314,117",Other,Application,2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T14:56:21Z,,0,0,09000064849d636f
FDA-2020-E-2364-0001,FDA,FDA-2020-E-2364,Letter from U S Patent and Trademark Office,Other,Letter(s),2020-12-31T05:00:00Z,2020,12,2020-12-31T05:00:00Z,,2020-12-31T14:55:22Z,,0,0,09000064849d636e